Clinical Trial: A Study of BL-M08D1 in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma and Other Solid Tumors

U.S., Sept. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07818486) titled 'A Study of BL-M08D1 in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma and Other Solid Tumors' on Sept. 08.

Brief Summary: This Phase Ib/II study is a clinical trial to evaluate the efficacy and safety of BL-M08D1 for Injection in patients with recurrent or metastatic nasopharyngeal carcinoma and other solid tumors.

Study Start Date: Sept., 2026

Study Type: INTERVENTIONAL

Condition: Nasopharyngeal Carcinoma (NPC) Solid Tumors

Intervention: DRUG: BL-M08D1

Administration by intravenous infusion for a cycle of 3 weeks.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.

Publi...